Overview
Nevro is a publicly traded medical device company specializing in spinal cord stimulation therapy for chronic pain, best known for its HF10 high-frequency SCS platform that operates at 10 kHz to reduce paresthesia. Their devices are FDA-approved for treating intractable back and leg pain.
More in Neuromodulation
Latest industry news
FDA Grants De Novo Approval to Modius Spero, Clearing First Neuromodulation Device for PTSD
2026-09-03 · Policy
Butterfly Network's BCI Chip Licensing Deal Rattles Investors as Shares Drop Nearly 10%
2026-09-02 · Industry
Merge Labs and Butterfly Network Unite to Push Ultrasound-Based BCIs Into the Mainstream
2026-09-01 · Industry
FDA Grants CorTec Second Breakthrough Device Designation for Its Brain-Computer Interface
2026-08-31 · Policy
Company details
Category
⚡ Neuromodulation
Location
Redwood City, USA
Funding
Public · NYSE: NVRO
Website
www.nevro.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →